Abstract
MicroRNAs (miRNAs) are small molecules found to have major regulatory roles in many biological processes. This review aims to provide an overview of the recent advances in knowledge of the role of miRNAs in fracture healing and bone repair. A search of the published literature was performed (using the PubMed database) to include all relevant studies published in English. These studies were then reviewed and the results condensed into this review paper. MiRNAs have now been shown to have significant alterations in expression levels in bone tissue in the presence of fractures. This is thought to be related to the process of fracture healing through effects on osteoblasts and bone growth factors. These small molecules are also detectable in the circulation where their expression appears to be altered by the presence of fractures. Although further research is required in this area, miRNAs may present an opportunity for future clinical applications in fracture management.
Similar content being viewed by others
References
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843–854
Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X et al (2003) A uniform system for microRNA annotation. RNA 9(3):277–279
Griffiths-Jones S (2010) miRBase: microRNA sequences and annotation. Curr Protoc Bioinform. doi:10.1002/0471250953.bi1209s29
Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20(5):515–524. doi:10.1101/gad.1399806
Winter J, Jung S, Keller S, Gregory RI, Diederichs S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11(3):228–234. doi:10.1038/ncb0309-228
He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522–531. doi:10.1038/nrg1379
Hammond SM, Caudy AA, Hannon GJ (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2(2):110–119. doi:10.1038/35052556
Fakhry M, Hamade E, Badran B, Buchet R, Magne D (2013) Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells 5(4):136–148. doi:10.4252/wjsc.v5.i4.136
Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T et al (2012) MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 8(4):212–227. doi:10.1038/nrendo.2011.234
Taipaleenmaki H, Bjerre Hokland L, Chen L, Kauppinen S, Kassem M (2012) Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur J Endocrinol 166(3):359–371. doi:10.1530/EJE-11-0646
Nugent M (2014) MicroRNA function and dysregulation in bone tumors: the evidence to date. Cancer Manag Res 6:15–25. doi:10.2147/CMAR.S53928
Nugent M (2015) MicroRNAs: exploring new horizons in osteoarthritis. Osteoarthr Cartil. doi:10.1016/j.joca.2015.10.018
Nugent M (2015) microRNA and bone cancer. Adv Exp Med Biol 889:201–230. doi:10.1007/978-3-319-23730-5_11
Nugent M, Miller N, Kerin MJ (2011) MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 37(8):649–654. doi:10.1016/j.ejso.2011.05.005
Nigro JM, Cho KR, Fearon ER, Kern SE, Ruppert JM, Oliner JD et al (1991) Scrambled exons. Cell 64(3):607–613
Dou C, Cao Z, Yang B, Ding N, Hou T, Luo F et al (2016) Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis. Sci Rep 6:21499. doi:10.1038/srep21499
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333–338. doi:10.1038/nature11928
Ernst C, Morton CC (2013) Identification and function of long non-coding RNA. Front Cell Neurosci 7:168. doi:10.3389/fncel.2013.00168
Liang WC, Fu WM, Wang YB, Sun YX, Xu LL, Wong CW et al (2016) H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA. Sci Rep 6:20121. doi:10.1038/srep20121
Huang Y, Zheng Y, Jia L, Li W (2015) Long noncoding RNA H19 promotes osteoblast differentiation via TGF-beta1/Smad3/HDAC signaling pathway by deriving miR-675. Stem Cells 33(12):3481–3492. doi:10.1002/stem.2225
Wang L, Wang Y, Li Z, Li Z, Yu B (2015) Differential expression of long noncoding ribonucleic acids during osteogenic differentiation of human bone marrow mesenchymal stem cells. Int Orthop 39(5):1013–1019. doi:10.1007/s00264-015-2683-0
De-Ugarte L, Yoskovitz G, Balcells S, Guerri-Fernandez R, Martinez-Diaz S, Mellibovsky L et al (2015) MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones. BMC Med Genom 8(1):75. doi:10.1186/s12920-015-0149-2
Garmilla-Ezquerra P, Sanudo C, Delgado-Calle J, Perez-Nunez MI, Sumillera M, Riancho JA (2015) Analysis of the bone microRNome in osteoporotic fractures. Calcif Tissue Int 96(1):30–37. doi:10.1007/s00223-014-9935-7
Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM et al (2009) The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthr Cartil 17(4):464–472. doi:10.1016/j.joca.2008.09.012
Watson L, Elliman SJ, Coleman CM (2014) From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair. Stem Cell Res Ther 5(2):51. doi:10.1186/scrt439
Huang J, Zhao L, Xing L, Chen D (2010) MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28(2):357–364. doi:10.1002/stem.288
Li H, Li T, Wang S, Wei J, Fan J, Li J et al (2013) miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res 10(3):313–324. doi:10.1016/j.scr.2012.11.007
Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S et al (2009) A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 106(49):20794–20799. doi:10.1073/pnas.0909311106
Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT et al (2015) miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget. doi:10.18632/oncotarget.6589
Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM et al (2008) A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 105(37):13906–13911. doi:10.1073/pnas.0804438105
Kim EJ, Kang IH, Lee JW, Jang WG, Koh JT (2013) MiR-433 mediates ERRgamma-suppressed osteoblast differentiation via direct targeting to Runx2 mRNA in C3H10T1/2 cells. Life Sci 92(10):562–568. doi:10.1016/j.lfs.2013.01.015
Schmidt Y, Simunovic F, Strassburg S, Pfeifer D, Stark GB, Finkenzeller G (2015) miR-126 regulates platelet-derived growth factor receptor-alpha expression and migration of primary human osteoblasts. Biol Chem 396(1):61–70. doi:10.1515/hsz-2014-0168
Schoolmeesters A, Eklund T, Leake D, Vermeulen A, Smith Q, Force Aldred S et al (2009) Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE 4(5):e5605. doi:10.1371/journal.pone.0005605
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF et al (2009) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119(12):3666–3677. doi:10.1172/JCI39832
Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J et al (2011) Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res 26(8):1953–1963. doi:10.1002/jbmr.377
Kapinas K, Delany AM (2011) MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res Ther 13(3):220. doi:10.1186/ar3325
Zhang JF, Fu WM, He ML, Wang H, Wang WM, Yu SC et al (2011) MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 22(21):3955–3961. doi:10.1091/mbc.E11-04-0356
Li H, Li T, Fan J, Fan L, Wang S, Weng X et al (2015) miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway. Cell Death Differ 22(12):1935–1945. doi:10.1038/cdd.2015.99
Sun Y, Xu L, Huang S, Hou Y, Liu Y, Chan KM et al (2015) mir-21 overexpressing mesenchymal stem cells accelerate fracture healing in a rat closed femur fracture model. Biomed Res Int 2015:412327. doi:10.1155/2015/412327
Tu M, Tang J, He H, Cheng P, Chen C (2016) MiR-142-5p promotes bone repair by maintaining osteoblast activity. J Bone Miner Metab. doi:10.1007/s00774-016-0757-8
Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A et al (2013) miR-214 targets ATF4 to inhibit bone formation. Nat Med 19(1):93–100. doi:10.1038/nm.3026
Li KC, Chang YH, Yeh CL, Hu YC (2016) Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges. Biomaterials 74:155–166. doi:10.1016/j.biomaterials.2015.09.046
Wang S, Tang C, Zhang Q, Chen W (2014) Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival. Int J Clin Exp Pathol 7(5):2209–2218
Hadjiargyrou M, Zhi J, Komatsu DE (2016) Identification of the microRNA transcriptome during the early phases of mammalian fracture repair. Bone 87:78–88. doi:10.1016/j.bone.2016.03.011
Waki T, Lee SY, Niikura T, Iwakura T, Dogaki Y, Okumachi E et al (2016) Profiling microRNA expression during fracture healing. BMC Musculoskelet Disord 17:83. doi:10.1186/s12891-016-0931-0
Waki T, Lee SY, Niikura T, Iwakura T, Dogaki Y, Okumachi E et al (2015) Profiling microRNA expression in fracture nonunions: Potential role of microRNAs in nonunion formation studied in a rat model. Bone Joint J 97-B(8):1144–1151. doi:10.1302/0301-620X.97B8.34966
Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi LJ, Zhou ZT et al (2012) Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. PLoS ONE 7(6):e38648. doi:10.1371/journal.pone.0038648
Baglio SR, Devescovi V, Granchi D, Baldini N (2013) MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene 527(1):321–331. doi:10.1016/j.gene.2013.06.021
Xie Q, Wang Z, Bi X, Zhou H, Wang Y, Gu P et al (2014) Effects of miR-31 on the osteogenesis of human mesenchymal stem cells. Biochem Biophys Res Commun 446(1):98–104. doi:10.1016/j.bbrc.2014.02.058
Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A et al (2012) Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 21(1):121–135. doi:10.1016/j.ccr.2011.12.015
Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y et al (2011) MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 112(7):1844–1856. doi:10.1002/jcb.23106
Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103(33):12481–12486. doi:10.1073/pnas.0605298103
Chen Q, Wang H, Liu Y, Song Y, Lai L, Han Q et al (2012) Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3. PLoS ONE 7(8):e42971. doi:10.1371/journal.pone.0042971
Haneklaus M, Gerlic M, O’Neill LA, Masters SL (2013) miR-223: infection, inflammation and cancer. J Intern Med 274(3):215–226. doi:10.1111/joim.12099
He B, Zhang ZK, Liu J, He YX, Tang T, Li J et al (2016) Bioinformatics and microarray analysis of miRNAs in aged female mice model implied new molecular mechanisms for impaired fracture healing. Int J Mol Sci. doi:10.3390/ijms17081260
Turchinovich A, Weiz L, Burwinkel B (2012) Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37(11):460–465. doi:10.1016/j.tibs.2012.08.003
Heneghan HMMN, Lowery AJ, Sweeney KJ, Kerin MJ (2009) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251:499–505
Nugent M, Miller N, Kerin MJ (2012) Circulating miR-34a levels are reduced in colorectal cancer. J Surg Oncol 106(8):947–952. doi:10.1002/jso.23174
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006. doi:10.1038/cr.2008.282
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513–10518. doi:10.1073/pnas.0804549105
Cai H, Zhao H, Tang J, Wu H (2014) Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma. J Surg Res. doi:10.1016/j.jss.2014.11.025
Panach L, Mifsut D, Tarin JJ, Cano A, Garcia-Perez MA (2015) Serum circulating microRNAs as biomarkers of osteoporotic fracture. Calcif Tissue Int 97(5):495–505. doi:10.1007/s00223-015-0036-z
Seeliger C, Karpinski K, Haug AT, Vester H, Schmitt A, Bauer JS et al (2014) Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res 29(8):1718–1728. doi:10.1002/jbmr.2175
Weilner S, Skalicky S, Salzer B, Keider V, Wagner M, Hildner F et al (2015) Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone 79:43–51. doi:10.1016/j.bone.2015.05.027
Murata K, Ito H, Yoshitomi H, Yamamoto K, Fukuda A, Yoshikawa J et al (2014) Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice. J Bone Miner Res 29(2):316–326. doi:10.1002/jbmr.2040
Kocijan R, Muschitz C, Geiger E, Skalicky S, Baierl A, Dormann R et al (2016) Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures. J Clin Endocrinol Metab 101(11):4125–4134. doi:10.1210/jc.2016-2365
Funding
There is no funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Mary Nugent declares that she has no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Nugent, M. MicroRNAs and Fracture Healing. Calcif Tissue Int 101, 355–361 (2017). https://doi.org/10.1007/s00223-017-0296-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-017-0296-x